Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Baracco

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Minerva Chirurgica|January 1, 1997
[Anesthesia in videolaparoscopic cholecystectomy. Our experience]T Verardo, E Baracco, M Ottonello
Cahiers D'Anesthesiologie|January 1, 1993
[Lumbosacral plexus block by the paravertebral route]E Baracco, T Verardo, M Gentili
Minerva Chirurgica|May 1, 1994
[Caudal anesthesia in proctological surgery]E Baracco, M Ottonello, T Verardo, et al.
Oncoimmunology|July 29, 2016
Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1Erika Vacchelli, Yuting Ma, Elisa E Baracco, et al.
Oncoimmunology|July 30, 2016
Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancerElisa E Baracco, Federico Pietrocola, Aitziber Buqué, et al.
Autophagy|August 18, 2016
Autophagy induction for the treatment of cancerFederico Pietrocola, Jonathan Pol, Erika Vacchelli, et al.
Minerva Chirurgica|May 10, 2003
[Day Surgery. Five years of experience and activity]L Ivaldi, M Perino, G Gambetta, et al.
Oncoimmunology|October 25, 2019
A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in miceSarah Lévesque, Julie Le Naour, Federico Pietrocola, et al.
Cancer Cell|July 15, 2016
Caloric Restriction Mimetics Enhance Anticancer ImmunosurveillanceFederico Pietrocola, Jonathan Pol, Erika Vacchelli, et al.
Science (New York, N.Y.)|October 31, 2015
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1Erika Vacchelli, Yuting Ma, Elisa E Baracco, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Minerva Chirurgica|January 1, 1997
[Anesthesia in videolaparoscopic cholecystectomy. Our experience]T Verardo, E Baracco, M Ottonello
Cahiers D'Anesthesiologie|January 1, 1993
[Lumbosacral plexus block by the paravertebral route]E Baracco, T Verardo, M Gentili
Minerva Chirurgica|May 1, 1994
[Caudal anesthesia in proctological surgery]E Baracco, M Ottonello, T Verardo, et al.
Oncoimmunology|July 29, 2016
Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1Erika Vacchelli, Yuting Ma, Elisa E Baracco, et al.
Oncoimmunology|July 30, 2016
Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancerElisa E Baracco, Federico Pietrocola, Aitziber Buqué, et al.
Autophagy|August 18, 2016
Autophagy induction for the treatment of cancerFederico Pietrocola, Jonathan Pol, Erika Vacchelli, et al.
Minerva Chirurgica|May 10, 2003
[Day Surgery. Five years of experience and activity]L Ivaldi, M Perino, G Gambetta, et al.
Oncoimmunology|October 25, 2019
A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in miceSarah Lévesque, Julie Le Naour, Federico Pietrocola, et al.
Cancer Cell|July 15, 2016
Caloric Restriction Mimetics Enhance Anticancer ImmunosurveillanceFederico Pietrocola, Jonathan Pol, Erika Vacchelli, et al.
Science (New York, N.Y.)|October 31, 2015
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1Erika Vacchelli, Yuting Ma, Elisa E Baracco, et al.
Pageof 2